FDA Inspection 1008038 — Montefiore's Institute for Reproductive Medicine and Health

Montefiore's Institute for Reproductive Medicine and Health — FEI 3003972343

The FDA completed an inspection of Montefiore's Institute for Reproductive Medicine and Health on March 22, 2017 in Hartsdale, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 22, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hartsdale, NY (United States)